The development of vaginal microbicides for the prevention of HIV transmission.
Weber
Jonathan
J
Wright-Fleming Institute, Imperial College London, United Kingdom. j.weber@imperial.ac.uk
Desai
Kamal
K
Darbyshire
Janet
J
D000282:Administration, Intravaginal; D000890:Anti-Infective Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D044966:Anti-Retroviral Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003075:Coitus; D005260:Female; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission*; D006801:Humans; D010344:Patient Advocacy; D017149:Private Sector; D017150:Public Sector; D013501:Surface-Active Agents / Q000008:administration & dosage / Q000627:therapeutic use
D000890:Anti-Infective Agents; D044966:Anti-Retroviral Agents; D013501:Surface-Active Agents